EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Effect of Transcatheter Aortic Valve Replacement Program Ratings on Case Selection

Tayyab Shah, Lin Yang, Yousuf Shah, Lauren Eberly, Sameed Ahmed M Khatana, Dharam J Kumbhani, Sammy Elmariah, Mohamad Alkhouli, Suzanne J Baron, Nimesh D Desai, Wilson Y Szeto, Kendall Lawrence und 6 weitere

JACC: Cardiovascular Interventions · 2025

DOI: 10.1016/j.jcin.2025.09.022 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JACC: Cardiovascular Interventions, 2025. Verfasst von Tayyab Shah und 17 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA. Hauptthemen laut MEDLINE: Transcatheter Aortic Valve Replacement, Quality Indicators, Health Care, Aortic Valve Stenosis, Hospitals. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Public reporting of transcatheter aortic valve replacement (TAVR) outcomes by U.S. News & World Report (USNWR) began in August 2020. The impact of these ratings on case selection has not been studied. OBJECTIVES: The aim of this study was to evaluate the impact of USNWR hospital TAVR ratings on patient risk profile. METHODS: Medicare fee-for-service beneficiaries undergoing TAVR at rated hospitals before and after the release of the USNWR ratings were identified. The causal effect of hospital ratings on patient risk profile (Elixhauser comorbidity score) was estimated using a difference-in-difference analysis comparing lower rated hospitals (average or below average) to high-performing hospitals. RESULTS: There were 138,147 TAVR patients in the prerating period and 50,650 patients in the postrating period treated at 618 hospitals. Prior to ratings release, all hospitals had similar yearly trends in TAVR patient risk profile. After ratings release, patients treated at lower rated hospitals exhibited a significantly greater decline in Elixhauser comorbidity score compared with those treated at higher rated hospitals (difference-in-difference estimator = -0.48; 95% CI: -0.66 to -0.31; P 20), lower rated hospitals exhibited a significantly greater decline (incidence rate ratio: 0.56; 95% CI: 0.51-0.62; P < 0.0001). CONCLUSIONS: Since 2020, there has been a substantial decline in the number of high-risk patients receiving TAVR across the United States, driven predominantly by hospitals that received lower USNWR TAVR ratings. This is likely, in part, driven by risk aversion, however, further research is required to understand the reasons behind this decline and identify mitigation strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcatheter Aortic Valve ReplacementQuality Indicators, Health CareAortic Valve StenosisHospitalsHumansUnited StatesRisk AssessmentRisk FactorsTreatment OutcomeAgedAged, 80 and overMaleMedicareFemaleTime FactorsComorbidity

Stichwörter der Autor:innen

U.S. News & World Reportaortic stenosisratingsrisk aversiontranscatheter aortic valve replacement

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Strong Memorial Hospital, Rochester, New York, USA.
  • Division of Cardiovascular Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania, USA; Penn Cardiovascular Outcomes, Quality, and Evaluative Research Center, University of Pennsylvania, Philad…
  • Division of Cardiology, Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
  • University of California, San Francisco School of Medicine, San Francisco, California, USA.

Zitieren

APA

Shah, T., Yang, L., Shah, Y., Eberly, L., Khatana, S. A. M., Kumbhani, D. J., Elmariah, S., Alkhouli, M., Baron, S. J., Desai, N. D., Szeto, W. Y., Lawrence, K., Fanaroff, A. C., Fiorilli, P. N., Tsao, A. L., Groeneveld, P. W., Giri, J., & Nathan, A. (2025). Effect of Transcatheter Aortic Valve Replacement Program Ratings on Case Selection. JACC: Cardiovascular Interventions. https://doi.org/10.1016/j.jcin.2025.09.022

Vancouver

Shah T, Yang L, Shah Y, Eberly L, Khatana SAM, Kumbhani DJ, et al. Effect of Transcatheter Aortic Valve Replacement Program Ratings on Case Selection. JACC: Cardiovascular Interventions. 2025. doi:10.1016/j.jcin.2025.09.022

BibTeX
@article{Shah2025,
  author = {Shah, Tayyab and Yang, Lin and Shah, Yousuf and Eberly, Lauren and Khatana, Sameed Ahmed M and Kumbhani, Dharam J and Elmariah, Sammy and Alkhouli, Mohamad and Baron, Suzanne J and Desai, Nimesh D and Szeto, Wilson Y and Lawrence, Kendall and Fanaroff, Alexander C and Fiorilli, Paul N and Tsao, Allison L and Groeneveld, Peter W and Giri, Jay and Nathan, Ashwin},
  title = {Effect of Transcatheter Aortic Valve Replacement Program Ratings on Case Selection},
  journal = {JACC: Cardiovascular Interventions},
  year = {2025},
  doi = {10.1016/j.jcin.2025.09.022}
}
Kostenlos starten →